A
PLACEBOCONTROLLED
TRIAL
OF
CEPHALEXIN
THERAPY
IN
THE
AMBULATORY
MANAGEMENT
OF
PATIENTS
WITH
CYSTIC
FIBROSIS
THE
EFFECTS
OF
ORAL
ADMINISTRATION
OF
CEPHALEXIN
WERE
EVALUATED
IN
A
DOUBLEBLIND
PLACEBOCONTROLLED
CROSSOVER
STUDY
IN
17
PATIENTS
WITH
MILD
TO
MODERATE
PULMONARY
DISEASE
DUE
TO
CYSTIC
FIBROSIS
FOR
TWO
YEARS
FOURMONTH
PERIODS
WITH
CEPHALEXIN
WERE
ALTERNATED
WITH
FOURMONTH
PLACEBO
PERIODS
THUS
PATIENTS
SERVED
AS
THEIR
OWN
CONTROL
SUBJECTS
FUNGAL
VULVOVAGINITIS
OCCURRED
IN
TWO
PATIENTS
DURING
CEPHALEXIN
THERAPY
DURING
THE
2
YEARS
OF
STUDY
THE
RATE
OF
COLONIZATION
WITH
MUCOID
STRAINS
OF
PSEUDOMONAS
AERUGINOSA
INCREASED
AND
DISEASE
SEVERITY
DETERIORATED
IN
PATIENTS
INITIALLY
COLONIZED
WITH
P
AERUGINOSA
SHORTTERM
COURSES
OF
SPUTUM
CULTURESPECIFIC
ANTIBIOTICS
IMPROVED
THE
COURSE
OF
SOME
PATIENTS
WITH
MILD
TO
MODERATE
PULMONARY
DISEASE
DUE
TO
CYSTIC
FIBROSIS
TREATMENT
WITH
CEPHALEXIN
DECREASED
THE
FREQUENCY
OF
RESPIRATORY
ILLNESSES
RESPIRATORY
ILLNESSES
REQUIRING
ANTIBIOTICS
AND
HOSPITALIZATIONS
FOR
RESPIRATORY
ILLNESSES
IN
PATIENTS
INITIALLY
COLONIZED
WITH
STAPHYLOCOCCUS
AUREUS
ANDOR
HAEMOPHILUS
INFLUENZAE
AND
ALSO
REDUCED
COLONIZATION
WITH
THESE
ORGANISMS
IMPROVED
WEIGHT
GAIN
IN
16
OF
17
PATIENTS
WAS
ASSOCIATED
WITH
PERIODS
OF
CEPHALEXIN
THERAPY
PULMONARY
FUNCTION
TESTS
REMAINED
STABLE
OR
IMPROVED
IN
10
OR
14
PATIENTS
DISEASE
SEVERITY
IMPROVED
IN
PATIENTS
NOT
COLONIZED
WITH
P
AERUGINOSA
